{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:39:24Z","timestamp":1793709564719,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jaip.2014.04.011","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T09:16:00Z","timestamp":1402132560000},"page":"434-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Treatment of Chronic Urticaria in Children with Antihistamines and Cyclosporine"],"prefix":"10.1016","volume":"2","author":[{"given":"Lisa","family":"Neverman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.04.011_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.iac.2013.07.010","article-title":"Acute urticaria","volume":"34","author":"Sabroe","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2014.04.011_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaci.2008.10.050","article-title":"What the first 10,000 patients with chronic urticaria have taught me: a personal journey","volume":"123","author":"Kaplan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60462-0","article-title":"Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0190-9622(91)70308-O","article-title":"Oral cyclosporine for severe chronic idiopathic urticaria and angioedema","volume":"25","author":"Fradin","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2014.04.011_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","article-title":"Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria","volume":"52","author":"Toubi","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.04.011_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1081\/IPH-100103860","article-title":"Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative","volume":"23","author":"Loria","year":"2001","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaip.2014.04.011_bib7","first-page":"285","article-title":"Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation","volume":"24","author":"Di Gioacchino","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2014.04.011_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporine in chronic \u2018idiopathic\u2019 urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.04.011_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1525-1470.2009.00869.x","article-title":"Experience with cyclosporine in children with chronic idiopathic urticaria","volume":"26","author":"Doshi","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2014.04.011_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/clpt.1987.145","article-title":"The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine","volume":"42","author":"Gengo","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2014.04.011_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-3164.2008.00697.x","article-title":"Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs","volume":"19","author":"Bizikova","year":"2008","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.jaip.2014.04.011_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0091-6749(73)80002-8","article-title":"Degree and duration of skin test suppression and side effects with antihistamines: a double blind controlled study with five antihistamines","volume":"51","author":"Cook","year":"1973","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0091-6749(75)90014-7","article-title":"Suppression of histamine-induced pruritus by three antihistaminic drugs","volume":"55","author":"Rhoades","year":"1975","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1081-1206(10)60123-8","article-title":"Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second generation antihistamines","volume":"102","author":"Dos Santos","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/j.1552-4604.1995.tb04131.x","article-title":"Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis","volume":"35","author":"Elder","year":"1995","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2014.04.011_bib16","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2011.01.045","article-title":"Clinical utility of the chronic urticaria index","volume":"127","author":"Biagtan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anai.2012.10.020","article-title":"Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders","volume":"110","author":"Cho","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","article-title":"Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity","volume":"110","author":"Sabroe","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2007.05.008","article-title":"Basophil secretion in chronic urticarial: autoantibody-dependent or not","volume":"120","author":"Kaplan","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib20","first-page":"CD008596","article-title":"Histamine H2-receptor antagonists for urticaria","volume":"3","author":"Fedorowicz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2014.04.011_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1081-1206(10)62677-4","article-title":"Leukotriene modifiers in chronic urticaria","volume":"83","author":"Bensch","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1034\/j.1398-9995.2000.00826.x","article-title":"Successful treatment of chronic urticaria","volume":"55","author":"Tedeschi","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.04.011_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2003.10.002","article-title":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results","volume":"113","author":"Bagenstose","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","article-title":"The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study","volume":"110","author":"Erbagci","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0378-6323.26735","article-title":"Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine","volume":"72","author":"Godse","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaip.2014.04.011_bib26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1365-2222.2002.01536.x","article-title":"Zafirlukast has no beneficial effects in the treatment of chronic urticaria","volume":"32","author":"Reimers","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.04.011_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/JAA.S3236","article-title":"Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review","volume":"2","author":"Di Lorenzo","year":"2008","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2014.04.011_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(86)90232-0","article-title":"Efficacy of doxepin in the treatment of chronic idiopathic urticaria","volume":"78","author":"Goldsobel","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2013.09.028","article-title":"Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria","volume":"112","author":"Orden","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaip.2013.06.003","article-title":"Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use","volume":"1","author":"Khan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2014.04.011_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.04.011_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.04.011_bib33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:07:52Z","timestamp":1761973672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219814001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213219814001822"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.04.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718493910.793500115","asserted-by":"object"}]},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Chronic Urticaria in Children with Antihistamines and Cyclosporine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2014.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}